alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › monitor

monitor

2 studies tagged monitor, dated 2023-06-21 to 2026-11-06. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Amyloid PET is a cost-effective exam to monitor Donanemab treatment in Alzheimer's disease 2026-11-06
  2. Usability of an app-based clinical decision support system to monitor psychotropic drug prescribing appropriateness in dementia 2023-06-21

Studies

2 studies carry this tag.

Date range

2023 to 2026

Top journals

  • International journal of medical informatics 1
  • Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Amyloid PET is a cost-effective exam to monitor Donanemab treatment in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026-11-06 Treatments

    Anti-amyloid monoclonal antibodies are the first drugs approved as disease targeted therapies for the treatment of early Alzheimer's disease (AD).

  2. Usability of an app-based clinical decision support system to monitor psychotropic drug prescribing appropriateness in dementia

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. International journal of medical informatics 2023-06-21 Cognitive tests and assessment

    In this pragmatic prospective cohort study we found that the PDT was used by elderly care physicians, with mediocre user satisfaction.

All topic tags with their study counts